FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thierry Le Chevalier

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ken A Olaussen; Robert Pirker; Helmut Popper; Angélique Robin; Jürgen Thomale; Elsa Vanhecke; Philippe Vielh; Julien Adam; Fabrice André; Elisabeth Brambilla; Frédéric Commo; Martin Filipits; Luc Friboulet; Louis Kayitalire; Thierry Le Chevalier; Jean-Charles Soria
PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outs.
luc friboulet; Stephen Graziano; Robert Kratzke; Thierry Le Chevalier; Gwénaël Le Teuff; Ken A Olaussen; Jean-Pierre Pignon; Robert Pirker; Florence Ponsonnailles; Angélique Robin; Vanessa Rousseau; Patrick Saulnier; Lesley Seymour; Frances A Shepherd; Eric Solary; Julien Adam; Fabrice André; Elisabeth Brambilla; Frédéric Commo; Nicolas Dorvault; Jean-Yves Douillard; Ariane Dunant; Martin Filipits; Annabelle Stoclin; Jürgen Thomale; Ming-Sound Tsao; Elsa Vanhecke; Jean-Charles Soria
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
Benjamin Besse; Thierry Le Chevalier
Developments in the treatment of early NSCLC: when to use chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thierry Le Chevalier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ken A Olaussen; Robert Pirker; Helmut Popper; Angélique Robin; Jürgen Thomale; Elsa Vanhecke; Philippe Vielh; Julien Adam; Fabrice André; Elisabeth Brambilla; Frédéric Commo; Martin Filipits; Luc Friboulet; Louis Kayitalire; Thierry Le Chevalier; Jean-Charles Soria
PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outs.
Lung cancer (Amsterdam, Netherlands) 2013;80(2):216-22.
2013: luc friboulet; Stephen Graziano; Robert Kratzke; Thierry Le Chevalier; Gwénaël Le Teuff; Ken A Olaussen; Jean-Pierre Pignon; Robert Pirker; Florence Ponsonnailles; Angélique Robin; Vanessa Rousseau; Patrick Saulnier; Lesley Seymour; Frances A Shepherd; Eric Solary; Julien Adam; Fabrice André; Elisabeth Brambilla; Frédéric Commo; Nicolas Dorvault; Jean-Yves Douillard; Ariane Dunant; Martin Filipits; Annabelle Stoclin; Jürgen Thomale; Ming-Sound Tsao; Elsa Vanhecke; Jean-Charles Soria
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
The New England journal of medicine 2013;368(12):1101-10.
2012: Benjamin Besse; Thierry Le Chevalier
Developments in the treatment of early NSCLC: when to use chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23 Suppl 10():x52-9.
2012: Martin J Edelman; Thierry Le Chevalier; Jean-Charles Soria
Maintenance therapy and advanced non-small-cell lung cancer: a skeptic's view.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(9):1331-6.
2012: William E Pierceall; Jean-Pierre Pignon; Robert Pirker; V Rousseau; K M Sprott; B E Ward; D T Weaver; F Andre; E Brambilla; Y Chen; M Filipits; C Jiang; Jeffery L Kutok; Thierry Le Chevalier; Ken A Olaussen; Jean-Charles Soria
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(9):2245-52.
2012: Benoit Lahon; Thierry Le Chevalier; Olaf Mercier; Sacha Mussot; Boriana Petkova; Dominique Fabre; Elie Fadel; Maria Rosa Ghigna; Philippe Dartevelle
Solitary fibrous tumor of the pleura: outcomes of 157 complete resections in a single center.
The Annals of thoracic surgery 2012;94(2):394-400.
2012: Catherine Delbaldo; Thierry Le Chevalier; Stefan Michiels; Estelle Rolland; Jean-Charles Soria; Nathalie Syz; Jean-Pierre Pignon
WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
Cochrane database of systematic reviews (Online) 2012;4():CD004569.
2011: Peter Goldstraw; James R Jett; Thierry Le Chevalier; Eric Lim; Andrew G Nicholson; David Ball; Frances A Shepherd
Non-small-cell lung cancer.
Lancet 2011;378(9804):1727-40.
2011: Thierry Le Chevalier
Management of early-stage non-small-cell lung cancer (NSCLC).
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S292-3.
2011: Thierry Le Chevalier
Non-small cell lung cancer: the challenges of the next decade.
Frontiers in oncology 2011;1():29.
2010: Jean-Charles Soria; Christophe Massard; Thierry Le Chevalier
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(12):2324-32.
2010: Thierry Le Chevalier
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 7():vii196-8.
2010: Frédéric Grassin; Nicolas Paleiron; Michel André; Raffaele Caliandro; Jean-Jacques Bretel; Philippe Terrier; Jacques Margery; Thierry Le Chevalier; Pierre Ruffié
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):893-7.
2010: Nermine S Kamal; Jean-Charles Soria; Jean Mendiboure; David Planchard; Ken A Olaussen; Vanessa Rousseau; Helmut Popper; Robert Pirker; Pascale Bertrand; Ariane Dunant; Thierry Le Chevalier; Martin Filipits; Pierre Fouret
MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(4):1206-15.
2010: Jean-Yves Douillard; Hélène Tribodet; Delphine Aubert; Frances A Shepherd; Rafael Rosell; Keyue Ding; Anne-Sophie Veillard; Lesley Seymour; Thierry Le Chevalier; Stephen Spiro; Richard Stephens; Jean Pierre Pignon
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(2):220-8.
2010: Rodrigo Arriagada; Ariane Dunant; Jean-Pierre Pignon; Bengt Bergman; Mariusz Chabowski; Dominique Grunenwald; Miroslaw Kozlowski; Cécile Le Péchoux; Robert Pirker; Maria-Izabel Sathler Pinel; M Tarayre; Thierry Le Chevalier
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):35-42.
2009: Benjamin Besse; Thierry Le Chevalier
Adjuvant or induction cisplatin-based chemotherapy for operable lung cancer.
Oncology (Williston Park, N.Y.) 2009;23(6):520-7.
2008: Benjamin Besse; Thierry Le Chevalier
Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5014-7.
2008: Martin Früh; Estelle Rolland; Jean-Pierre Pignon; Lesley Seymour; Keyue Ding; Hélène Tribodet; Timothy Winton; Thierry Le Chevalier; Giorgio V Scagliotti; Jean Yves Douillard; Stephen Spiro; Frances A Shepherd
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3573-81.
2008: Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3552-9.
2007: Johan Vansteenkiste; Primo Lara; Thierry Le Chevalier; Jean-Luc Breton; Philip Bonomi; Alan B Sandler; Mark A Socinski; Catherine Delbaldo; Brent McHenry; David Lebwohl; Ronald Peck; Martin J Edelman; Mark Edelman
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3448-55.
2007: Martin Filipits; Vincent Haddad; Katharina Schmid; Anh Huynh; Ariane Dunant; Fabrice André; Elisabeth Brambilla; Rolf Stahel; Jean-Pierre Pignon; Jean-Charles Soria; Helmut H Popper; Thierry Le Chevalier; Robert Pirker
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3892-8.
2007: Martin Filipits; Robert Pirker; Ariane Dunant; Sylvie Lantuejoul; Katharina Schmid; Anh Huynh; Vincent Haddad; Fabrice André; Rolf Stahel; Jean-Pierre Pignon; Jean-Charles Soria; Helmut H Popper; Thierry Le Chevalier; Elisabeth Brambilla
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2735-40.
2007: Laurent Taillade; Frédérique Penault-Llorca; Thomas Boulet; Pierre Fouret; Stefan Michiels; Estelle Taranchon; Giannis Mountzios; Pierre Validire; Julien Domont; Philippe Girard; Dominique Grunenwald; Thierry Le Chevalier; Jean-Charles Soria
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(6):1043-50.
2007: Catherine Delbaldo; Stefan Michiels; Estelle Rolland; Nathalie Syz; Jean-Charles Soria; Thierry Le Chevalier; Jean-Pierre Pignon
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
Cochrane database of systematic reviews (Online) 2007;(4):CD004569.
2006: Benjamin Besse; Stéphane Vignot; Thierry Le Chevalier
[Neoadjuvant chemotherapy in non small cell lung cancer].
Bulletin du cancer 2006;93(11):1087-92.
2006: Giuseppe Giaccone; Marielle Gallegos Ruiz; Thierry Le Chevalier; Nick Thatcher; Egbert Smit; Jose A Rodriguez; Pasi A Janne; Dalila Oulid-Aissa; Jean-Charles Soria
Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6049-55.
2006: Ken A Olaussen; Ariane Dunant; Pierre Fouret; Elisabeth Brambilla; Fabrice André; Vincent Haddad; Estelle Taranchon; Martin Filipits; Robert Pirker; Helmut H Popper; Rolf Stahel; Laure Sabatier; Jean-Pierre Pignon; Thomas Tursz; Thierry Le Chevalier; Jean-Charles Soria
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
The New England journal of medicine 2006;355(10):983-91.
2006: Yohann Loriot; Jean-Charles Soria; Thierry Le Chevalier
Expanding role of chemotherapy in lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 10():x101-7.
2006: Anne Aupérin; Cécile Le Péchoux; Jean-Pierre Pignon; C Koning; Branislav Jeremic; G Clamon; L Einhorn; D Ball; M G Trovo; H J M Groen; J A Bonner; Thierry Le Chevalier; Rodrigo Arriagada
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):473-83.
2006: Masahiro Tsuboi; Thierry Le Chevalier
Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.
Medical oncology (Northwood, London, England) 2006;23(2):161-70.
2005: T Dutu; Stefan Michiels; Pierre Fouret; Frédérique Penault-Llorca; Pierre Validire; Simone Benhamou; Estelle Taranchon; Luc Morat; Dominique Grunenwald; Thierry Le Chevalier; Laure Sabatier; Jean-Charles Soria
Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(12):1906-14.
2005: Ariane Dunant; Jean-Pierre Pignon; Thierry Le Chevalier
Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):5017s-5021s.
2005: Thomas J Lynch; Jeffrey A. Bogart; Walter Curran; Malcolm M DeCamp; David R Gandara; Glenwood Goss; Claudia I Henschke; James R Jett; Bruce E Johnson; Karen L Kelly; Thierry Le Chevalier; James L Mulshine; Giorgio V Scagliotti; Joan H Schiller; Alice Shaw; Nick Thatcher; Everett E Vokes; Douglas E Wood; Carol Hart
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):4981s-4983s.
2005: Caroline Robert; Jean-Charles Soria; Alain Spatz; Axel Le Cesne; David Malka; Patricia Pautier; Janine Wechsler; Catherine Lhomme; Bernard Escudier; Valérie Boige; Jean-Pierre Armand; Thierry Le Chevalier
Cutaneous side-effects of kinase inhibitors and blocking antibodies.
The lancet oncology 2005;6(7):491-500.
2005: Julien Dômont; Jean-Charles Soria; Thierry Le Chevalier
Adjuvant chemotherapy in early-stage non-small cell lung cancer.
Seminars in oncology 2005;32(3):279-83.
2005: Katherine M W Pisters; Thierry Le Chevalier
Adjuvant chemotherapy in completely resected non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(14):3270-8.
2005: Cesare Gridelli; Matti Aapro; Andrea Ardizzoni; Lodovico Balducci; Filippo De Marinis; Karen Kelly; Thierry Le Chevalier; Christian Manegold; Francesco Perrone; Rafael Rosell; Frances Shepherd; Luigi De Petris; Massimo Di Maio; Corey Langer
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3125-37.
2005: Thierry Le Chevalier; Rodrigo Arriagada; Jean-Pierre Pignon; Giorgio V Scagliotti
Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?
The lancet oncology 2005;6(3):182-4.
2005: Mustafa Erman; Dominique Grunenwald; Frédérique Penault-Llorca; Julien Grenier; Benjamin Besse; Pierre Validire; Luc Morat; Philippe Girard; Thierry Le Chevalier; Laure Sabatier; Jean-Charles Soria
Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.
Lung cancer (Amsterdam, Netherlands) 2005;47(3):315-23.
2005: Rodrigo Arriagada; Marc Spielmann; serge koscielny; Thierry Le Chevalier; Thierry Delozier; Monique Rémé-Saumon; Muriel Ducourtieux; Thomas Tursz; Catherine Hill
Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancer.
Acta oncologica (Stockholm, Sweden) 2005;44(5):458-66.
2005: Stéphane Vignot; Jean-Philippe Spano; Sylvie Lantuejoul; Fabrice André; Thierry Le Chevalier; Jean-Charles Soria
Chemoprevention of lung cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2005;166():145-65.
2005: Thierry Le Chevalier; Giorgio V Scagliotti; R Natale; S Danson; Rafael Rosell; R Stahel; P Thomas; Robin Rudd; J Vansteenkiste; N Thatcher; C Manegold; Jean-Louis Pujol; nico van zandwijk; C Gridelli; Jan P van Meerbeeck; Lucio Crino; A Brown; P Fitzgerald; Mike Aristides; J H Schiller
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
Lung cancer (Amsterdam, Netherlands) 2005;47(1):69-80.
2004: Thierry Le Chevalier; Thomas Lynch
Adjuvant treatment of lung cancer: current status and potential applications of new regimens.
Lung cancer (Amsterdam, Netherlands) 2004;46 Suppl 2():S33-9.
2004: Cécile Le Péchoux; Frédéric Dhermain; JJ Bretel; Agnès Laplanche; Ariane Dunant; M Tarayre; Pierre Ruffié; Thierry Le Chevalier
[Modalities of radiotherapy in small cell lung cancer: thoracic radiotherapy and prophylactic cerebral irradiation].
Revue de pneumologie clinique 2004;60(5 Pt 2):3S91-103.
2004: Mustafa Erman; Luigi Moretti; Jean-Charles Soria; Thierry Le Chevalier; Paul Van Houtte
Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
Seminars in radiation oncology 2004;14(4):315-21.
2004: Benjamin Besse; Céline Candé; Jean-Philippe Spano; Antoine Martin; David Khayat; Thierry Le Chevalier; Thomas Tursz; Laure Sabatier; Jean-Charles Soria; Guido Kroemer
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5665-9.
2004: Christian Monnerat; Thierry Le Chevalier; Karen Kelly; Coleman K Obasaju; Julie R Brahmer; Silvia Novello; Takashi Nakamura; Astra M Liepa; Laurence Bozec; Paul A Bunn; David S Ettinger
Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5439-46.
2004: Benjamin Besse; Thierry Le Chevalier; Jean-Charles Soria
[Predicting response to Iressa: unexpected mechanism].
Médecine sciences : M/S 2004;20(8-9):750-1.
2004: Catherine Delbaldo; Stefan Michiels; Nathalie Syz; Jean-Charles Soria; Thierry Le Chevalier; Jean-Pierre Pignon
Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis.
JAMA : the journal of the American Medical Association 2004;292(4):470-84.
2004: Suzette Delaloge; Antonio Llombart; Mario Di Palma; Jean-Marc Tourani; Francois Turpin; Lan Ni; S T Forgue; Thierry Le Chevalier
Gemcitabine in patients with solid tumors and renal impairment: a pharmacokinetic phase I study.
American journal of clinical oncology 2004;27(3):289-93.
2004: Amine Masmoudi; Thierry Le Chevalier; Laure Sabatier; Jean-Charles Soria
[Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Bulletin du cancer 2004;91 Spec No():S77-84.
2004: Jean-Philippe Spano; Fabrice Andre; Luc Morat; Laure Sabatier; Benjamin Besse; Christophe Combadiere; Philippe Deterre; A Martin; J Azorin; D Valeyre; David Khayat; Thierry Le Chevalier; Jean-Charles Soria
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(4):613-7.
2004: Christian Monnerat; R Henriksson; Thierry Le Chevalier; Silvia Novello; Patrice Berthaud; Sandrine Faivre; Eric Raymond
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):316-23.
2004: Rodrigo Arriagada; Bengt Bergman; Ariane Dunant; Thierry Le Chevalier; Jean-Pierre Pignon; Johan Vansteenkiste
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
The New England journal of medicine 2004;350(4):351-60.
2004: Laurent Taillade; Jean-Charles Soria; Fabrice André; Dominique Grunenwald; Ariane Dunant; Jean-Pierre Pignon; Thierry Le Chevalier
[Adjuvant chemotherapy in non-small cell lung cancer].
Bulletin du cancer 2004;91(1):63-7.
2004: David Planchard; Jean-Charles Soria; Stefan Michiels; Dominique Grunenwald; Pierre Validire; Raffaele Caliandro; Philippe Girard; Thierry Le Chevalier
Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.
Cancer 2004;100(1):28-35.
2003: Yannick Le Guen; Laure Sabatier; Thierry Le Chevalier; Jean-Charles Soria
[Molecular therapy targets in lung cancer].
Bulletin du cancer 2003;90(12):1055-61.
2003: J D Cox; Thierry Le Chevalier; Rodrigo Arriagada; H Choy; Walter Curran; M Fukuoka; P Harper; Ritsuko Komaki; C Le Pechoux; Yolande Lievens; R Rami-Porta; N Ready; William T Sause; M Stuschke; N Thatcher
Management of unresectable non-small cell carcinoma of the lung (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2003;42 Suppl 1():S15-6.
2003: Bruce E Johnson; Thomas Fischer; Berthold Fischer; David Dunlop; Danny Rischin; Sandra Silberman; Mildred Ortu Kowalski; Deanne Sayles; Sasa Dimitrijevic; Christopher Fletcher; Jason Hornick; Ravi Salgia; Thierry Le Chevalier
Phase II study of imatinib in patients with small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5880-7.
2003: Jérôme Fayette; Thierry Le Chevalier; Jean-Charles Soria
[Therapeutic implications of epidermal growth factor receptor in lung cancer].
Bulletin du cancer 2003;90 Spec No():S233-40.
2003: Thierry Le Chevalier
[Status of current adjuvant therapies in NSCLC].
Revue de pneumologie clinique 2003;59(5 Pt 2):S7-10.
2003: Thierry Le Chevalier
The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.
Seminars in oncology 2003;30(4 Suppl 10):37-44.
2003: Paul A Bunn; Frances A Shepherd; Alan B Sandler; Thierry Le Chevalier; Chandra P Belani; Paris A Kosmidis; Giorgio V Scagliotti; Giuseppe Giaccone
Ongoing and future trials of biologic therapies in lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S175-86.
2003: Silvia Novello; Thierry Le Chevalier
Chemotherapy for non-small-cell lung cancer. Part 2: Advanced disease.
Oncology (Williston Park, N.Y.) 2003;17(4):457-64, 469-71; discussion 471, 478-80, 483-4.
2003: Silvia Novello; Thierry Le Chevalier
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
Oncology (Williston Park, N.Y.) 2003;17(3):357-64.
2003: Karim Fizazi; H Doubre; Thierry Le Chevalier; A Riviere; Juliette Viala; C Daniel; L Robert; P Barthélemy; A Fandi; Pierre Ruffié
Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):349-54.
2002: Sandrine Faivre; Thierry Le Chevalier; Christian Monnerat; François Lokiec; Silvia Novello; J Taieb; Patricia Pautier; Catherine Lhommé; Pierre Ruffié; Louis Kayitalire; Jean-Pierre Armand; Eric Raymond
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1479-89.
2002: Rodrigo Arriagada; Marc Spielmann; serge koscielny; Thierry Le Chevalier; Thierry Delozier; Muriel Ducourtieux; Thomas Tursz; Catherine Hill
Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1378-86.
2002: Fabrice Andre; Noël Emile Célestin Schartz; Mojgan Movassagh; Caroline Flament; Patricia Pautier; Philippe Morice; Christophe Pomel; Catherine Lhomme; Bernard Escudier; Thierry Le Chevalier; Thomas Tursz; Sebastian Amigorena; Graça Raposo; Eric Angevin; Laurence Zitvogel
Malignant effusions and immunogenic tumour-derived exosomes.
Lancet 2002;360(9329):295-305.
2002: Thierry Le Chevalier
Epothilones: a new generation of microtubule-stabilizing compounds.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(4):S13-4.
2002: Thierry Le Chevalier
Gemcitabine and pemetrexed (Alimta) in thoracic cancers: present and future perspectives. Introduction and current controversies.
Seminars in oncology 2002;29(3 Suppl 9):43-6.
2002: Catherine Delbaldo; Sandrine Faivre; Christian Monnerat; Thierry Le Chevalier
[New drugs in bronchial cancer].
Presse médicale (Paris, France : 1983) 2002;31(17):802-9.
2002: Rodrigo Arriagada; Thierry Le Chevalier; Alain Rivière; P Chomy; I Monnet; Etienne Bardet; J A Santos-Miranda; C Le Péhoux; M Tarayre; Simone Benhamou; Agnès Laplanche
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(5):748-54.
2002: Dominique Grunenwald; Christian Mazel; Philippe Girard; Giulia Veronesi; Lorenzo Spaggiari; Dominique Gossot; Denis Debrosse; Raffaele Caliandro; Jean-Luc Le Guillou; Thierry Le Chevalier
Radical en bloc resection for lung cancer invading the spine.
The Journal of thoracic and cardiovascular surgery 2002;123(2):271-9.
2002: Catherine Delbaldo; Cécile Le Péchoux; Thierry Le Chevalier
Combined modality treatment of lung cancer (NSCLC and SCLC).
Cancer chemotherapy and biological response modifiers 2002;20():677-95.
2002: S Novello; Thierry Le Chevalier
Use of chemo-radiotherapy in locally advanced non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(2):292-9.
2001: Jean-Charles Soria; D Brisgand; Thierry Le Chevalier
Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(12):1667-70.
2001: Silvia Novello; Thierry Le Chevalier
ALIMTA (pemetrexed disodium, LY231514, MTA): clinical experience in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S107-9.
2001: Silvia Novello; Thierry Le Chevalier
Is there a standard strategy in the management of locally advanced non-small cell lung cancer?
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S9-14.
2001: Silvia Novello; Thierry Le Chevalier
Ongoing/planned studies in France Stage I-II NSCLC.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 3():S59-61.
2001: Dominique Grunenwald; F André; Cécile Le Péchoux; Philippe Girard; C Lamer; A Laplanche; M Tarayre; Rodrigo Arriagada; Thierry Le Chevalier
Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.
The Journal of thoracic and cardiovascular surgery 2001;122(4):796-802.
2001: Silvia Novello; Thierry Le Chevalier
European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer.
Seminars in oncology 2001;28(4 Suppl 14):3-9.
2001: Fabrice Andre; Dominique Grunenwald; Jean-Louis Pujol; Philippe Girard; Antoine Dujon; Laurent Brouchet; Pierre-Yves Brichon; Virginie Westeel; Thierry Le Chevalier
Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?
Cancer 2001;91(12):2394-400.
2001: Mahasti Saghatchian; Karim Fizazi; C Borel; Michel Ducreux; Pierre Ruffié; Thierry Le Chevalier; Christine Théodore
Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):535-40.
2001: Jean-Louis Pujol; Jean-Pierre Daurès; Alain Rivière; Elisabeth Quoix; Virginie Westeel; Xavier Quantin; Jean-Luc Breton; E Lemarié; M Poudenx; Bernard Milleron; denis moro-sibilot; Didier Debieuvre; Thierry Le Chevalier
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.
Journal of the National Cancer Institute 2001;93(4):300-8.
2001: Thierry Le Chevalier; D Brisgand; Jean-Charles Soria; Jean-Yves Douillard; Jean-Louis Pujol; P Ruffie; V Aberola; S Cigolari
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
The oncologist 2001;6 Suppl 1():8-11.
2000: J B Meric; Sandrine Faivre; Christian Monnerat; N Adi Vago; Thierry Le Chevalier; Jean-Pierre Armand; Eric Raymond
[Zd 1839 "Iressa"].
Bulletin du cancer 2000;87(12):873-6.
2000: Fabrice Andre; Dominique Grunenwald; Jean-Pierre Pignon; Antoine Dujon; Jean-Louis Pujol; Pierre-Yves Brichon; Laurent Brouchet; Elisabeth Quoix; Virginie Westeel; Thierry Le Chevalier
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):2981-9.
2000: Karim Fizazi; Raffaele Caliandro; Patrick Soulié; A Fandi; C Daniel; A Bedin; H Doubre; Juliette Viala; Jean-François Rodier; L Trandafir; Thierry Le Chevalier; Esteban Cvitkovic; Jean-Pierre Armand; Pierre Ruffié
Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma.
European journal of cancer (Oxford, England : 1990) 2000;36(12):1514-21.
2000: Jean-Pierre Delord; Eric Raymond; M Chaouche; P Ruffie; Michel Ducreux; Sandrine Faivre; Valérie Boige; Thierry Le Chevalier; Olivier Rixe; Eric Baudin; Patricia Pautier; J M Rodier; N Chouaki; Bernard Escudier; Louis Kayitalire; Jean-Pierre Armand
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):73-9.
1999: Fabrice André; Dominique Grunenwald; Philippe Girard; P Van Houtte; U Pastorino; Thierry Le Chevalier
[Non-small cell bronchial cancer with mediastinal invasion].
Bulletin du cancer 1999;86(10):867-70.
1999: Thierry Le Chevalier; J Bérille; J R Zalcberg; M J Millward; A Monnier; J Y Douillard; MJ McKeage; R James; F Soulas; C Loret; N Bougon; J P Bizzari
Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer.
Seminars in oncology 1999;26(3 Suppl 11):13-8.
1999: O Merimsky; Thierry Le Chevalier; Gilles Missenard; C Lepechoux; I Cojean-Zelek; Benoît Mesurolle; Axel Le Cesne
Management of cancer in pregnancy: a case of Ewing's sarcoma of the pelvis in the third trimester.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):345-50.
1999: O Merimsky; P Terrier; A Stanca; Thierry Le Chevalier; Marc Spielmann; Thomas Tursz; Axel Le Cesne
Liver metastases from extremity soft tissue sarcoma.
American journal of clinical oncology 1999;22(1):70-2.
1998: Thierry Le Chevalier; A Monnier; Jean-Yves Douillard; P Ruffie; X S Sun; L Belli; N Ibrahim; N Bougon; J Bérille
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(13):2032-6.
1998: Antonio Llombart-Cussac; Xavier Pivot; A Rhor-Alvarado; Axel Le Cesne; Thierry Le Chevalier; Thomas Tursz; Marc Spielmann
First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study.
Oncology 1998;55(5):384-90.
1998: Thierry Le Chevalier
Adjuvant chemotherapy in non-small cell lung cancer.
Seminars in oncology 1998;25(4 Suppl 9):62-5.
1998: Karim Fizazi; I Cojean; Jean-Pierre Pignon; Olivier Rixe; Michel Gatineau; S Hadef; Rodrigo Arriagada; P Baldeyrou; E Comoy; Thierry Le Chevalier
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Cancer 1998;82(6):1049-55.
1998: Cécile Le Péchoux; Rodrigo Arriagada; Thierry Le Chevalier; M Tarayre; Pierre Ruffié; P Baldeyrou; JJ Bretel; B Pellae-Cosset; C Hanzen; M Martin; P Duroux
Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(3):257-61.
1998: Karim Fizazi; Stéphane Culine; Jean Pierre Droz; Marie-José Terrier-Lacombe; Christine Théodore; Pierre Wibault; O Rixe; Pierre Ruffié; Thierry Le Chevalier
Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?
European journal of cancer (Oxford, England : 1990) 1998;34(3):347-52.
1998: Karim Fizazi; Stéphane Culine; Jean Pierre Droz; Andrew Kramar; Christine Théodore; Pierre Ruffié; Thierry Le Chevalier
Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):725-32.
1998: Michel Gatineau; Thierry Le Chevalier
[Update on pulmonary cancerology. What is new in 1997].
Bulletin du cancer 1998;85(1):50-2.
1997: Philippe Girard; L Spaggiari; P Baldeyrou; Thierry Le Chevalier; Axel Le Cesne; B Escudier; M Filaire; Dominique Grunenwald
Should the number of pulmonary metastases influence the surgical decision?
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1997;12(3):385-91; discussion 392.
1997: Jean-Louis Pujol; Jean-Yves Douillard; Alain Rivière; Elisabeth Quoix; jean leon lagrange; P Berthaud; M Bardonnet-Comte; Valerie Laforest; V Gautier; Bernard Milleron; F Chomy; P Chomy; Dominique Spaeth; Thierry Le Chevalier
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):2082-9.
1997: Axel Le Cesne; Rodrigo Arriagada; Dominique Grunenwald; P Baldeyrou; Philippe Girard; JJ Bretel; Thierry Le Chevalier
[New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].
Bulletin du cancer 1997;84(4):413-9.
1997: Thierry Le Chevalier; M Gottfried
Single-agent gemcitabine in non-small cell lung cancer: the French experience.
Seminars in oncology 1997;24(2 Suppl 7):S7-47-S7-49.
1997: Karim Fizazi; Stéphane Culine; Jean Pierre Droz; Thierry Le Chevalier; Pierre Ruffié; Christine Théodore
[Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology].
Bulletin du cancer 1997;84(3):313-27.
1997: Thierry Le Chevalier; M Gottfried; U Gatzemeier; F Shepherd; P Weynants; B Cottier; H J Groen; R Rosso; K Mattson; H Cortes-Funes; M Tonato; Ronald L Burkes; Maurizio Voi; A Ponzio
[A phase II multicenter study of gemcitabine in non small cell lung cancers].
Bulletin du cancer 1997;84(3):282-8.
1997: Dominique Grunenwald; L Spaggiari; Philippe Girard; P Baldeyrou; R Posea; C Lamer; P Bourel; Thierry Le Chevalier
Lung resection for recurrence after pneumonectomy for metastases.
Bulletin du cancer 1997;84(3):277-81.
1997: J L Molitor; Antonio Llombart; Jean-Marc Guinebretière; L Zemoura; Marc Spielmann; Genevieve Contesso; Florent de Vathaire; Laurent Zelek; L Kaylitalire; Thierry Le Chevalier; J Genin
[Angiosarcoma of the breast. Apropos of 8 cases and review of the literature].
Bulletin du cancer 1997;84(2):206-11.
1997: Miriam Merad; Axel Le Cesne; P Baldeyrou; Benoît Mesurolle; Thierry Le Chevalier
Docetaxel and interstitial pulmonary injury.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):191-4.
1997: JJ Bretel; Rodrigo Arriagada; Thierry Le Chevalier; P Baldeyrou; Dominique Grunenwald; Cécile Le Péchoux; B Pellae-Cosset; Pierre Ruffié
[Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 1997;1(2):148-53.
1997: J Dancey; Thierry Le Chevalier
Non-small cell lung cancer: an overview of current management.
European journal of cancer (Oxford, England : 1990) 1997;33 Suppl 1():S2-7.
1997: Karim Fizazi; fadi farhat; Christine Theodore; Olivier Rixe; Axel Le Cesne; E Comoy; Thierry Le Chevalier
Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
British journal of cancer 1997;75(1):76-8.
1996: T Tursz; A L Cesne; P Baldeyrou; E Gautier; Paule Opolon; C Schatz; A Pavirani; M Courtney; D Lamy; Thierry Ragot; P Saulnier; Antoine Andremont; Roger Monier; Michel Perricaudet; Thierry Le Chevalier
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients.
Journal of the National Cancer Institute 1996;88(24):1857-63.
1996: Thierry Le Chevalier
[Chemotherapy of non-small-cell lung cancers].
Presse médicale (Paris, France : 1983) 1996;25(35):1699-703.
1996: Thierry Le Chevalier
Single-agent activity of gemcitabine in advanced non-small cell lung cancer.
Seminars in oncology 1996;23(5 Suppl 10):36-42.
1996: Karim Fizazi; Axel Le Cesne; N Dohollou; S Affaied; Marc Spielmann; Thierry Le Chevalier
Serum neuron-specific enolase (NSE) as a tumour marker for the Ewing's sarcoma family of tumours.
European journal of cancer (Oxford, England : 1990) 1996;32A(10):1823-4.
1996: Jean-Charles Soria; Karim Fizazi; M Merad; Thierry Le Chevalier
[Inappropriate antidiuretic hormone secretion disclosing a second primary lung cancer 5 years after complete remission of a small cell lung carcinoma].
Bulletin du cancer 1996;83(8):605-8.
1996: Cécile Le Péchoux; Rodrigo Arriagada; Thierry Le Chevalier; JJ Bretel; B P Cosset; Pierre Ruffié; P Baldeyrou; Dominique Grunenwald
Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
International journal of radiation oncology, biology, physics 1996;35(3):519-25.
1996: Thierry Le Chevalier; D Brisgand; Jean-Louis Pujol; Jean-Yves Douillard; A Monnier; Alain Rivière; P Chomy; A Le Groumellec; P Ruffie; M Gottfried; M H Gaspard; Christine Chevreau; Vicente Alberola; S Cigolari; F Besson; A Martinez; M Besenval; P Berthaud; Thomas Tursz
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Bulletin du cancer 1996;83(5):385-94.
1996: Patrick Soulié; Pierre Ruffié; L Trandafir; I Monnet; Anne Tardivon; Philippe Terrier; Esteban Cvitkovic; Thierry Le Chevalier; Jean-Pierre Armand
Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):878-85.
1996: U Gatzemeier; F A Shepherd; Thierry Le Chevalier; P Weynants; B Cottier; H J Groen; R Rosso; K Mattson; H Cortes-Funes; M Tonato; R L Burkes; M Gottfried; M Voi
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):243-8.
1995: F Thomas; Rodrigo Arriagada; Marc Spielmann; H Mouriesse; Thierry Le Chevalier; F Fontaine; Thomas Tursz
Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Cancer 1995;76(11):2286-90.
1995: Axel Le Cesne; G Chabot; J Bérille; C Lucas; M Baud; Alain Gouyette; Michel Marty; Thierry Le Chevalier
Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;13(1):69-78.
1995: Thierry Le Chevalier
Docetaxel: meeting the challenge of non-small cell lung cancer management.
Anti-cancer drugs 1995;6 Suppl 4():13-7.
1995: Axel Le Cesne; E Antoine; Marc Spielmann; Thierry Le Chevalier; E Brain; C Toussaint; Nicolas Janin; L Kayitalire; F Fontaine; J Genin
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1600-8.
1995: Axel Le Cesne; Thierry Le Chevalier; Rodrigo Arriagada
Impact of chemotherapy on survival in locally advanced non-small cell lung cancer: the Gustave-Roussy experience.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S79-85.
1995: Jean-Louis Pujol; Thierry Le Chevalier; P Ray; V Gautier; P Rouanet; Rodrigo Arriagada; D Grunenwald; François-Bernard Michel
Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S107-18.
1995: Rodrigo Arriagada; Thierry Le Chevalier; F Borie; Alain Rivière; P Chomy; I Monnet; Anne Tardivon; F Viader; M Tarayre; S Benhamou
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.
Journal of the National Cancer Institute 1995;87(3):183-90.
1995: Axel Le Cesne; Thierry Le Chevalier; Rodrigo Arriagada
Dealing with initial chemotherapy doses: a new basis for treatment optimisation in limited small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6 Suppl 3():S53-6.
1995: I Cojean; Thierry Le Chevalier
Chemotherapy of stage IIIB and IV non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6 Suppl 3():S41-4.
1994: Thierry Le Chevalier; Jean-Louis Pujol; Jean-Yves Douillard; Vicente Alberola; A Monnier; A Riviere; P Lianes; P Chomy; S Cigolari; F Besson
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Seminars in oncology 1994;21(5 Suppl 10):28-33; discussion 33-4.
1994: Karim Fizazi; I Cojean; Axel Le Cesne; L Kayitalire; Thierry Le Chevalier; Thomas Tursz; Marc Spielmann
[Soft tissue sarcomas: general review].
Bulletin du cancer 1994;81(10):835-52.
1994: Jean-Pierre Pignon; M Tarayre; A Auquier; Rodrigo Arriagada; Thierry Le Chevalier; Pierre Ruffié; Alain Rivière; I Monnet; P Chomy; C Tuchais
Triangular test and randomized trials: practical problems in a small cell lung cancer trial.
Statistics in medicine 1994;13(13-14):1415-21.
1994: Jean-Louis Pujol; A Monnier; J Berille; M L Cerrina; J Y Douillard; Alain Rivière; A Grandgirard; S Gouva; J P Bizzari; Thierry Le Chevalier
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.
British journal of cancer 1994;69(6):1136-40.
1994: Rodrigo Arriagada; Thierry Le Chevalier; Pierre Ruffié; P Chomy; H de Cremoux
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S289-98.
1994: Thierry Le Chevalier; Rodrigo Arriagada; Elisabeth Quoix; P Ruffie; M Martin; Jean-Yves Douillard; M Tarayre; M J Lacombe-Terrier; Agnès Laplanche
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S239-44.
1994: Thierry Le Chevalier; D Brisgand; Jean-Yves Douillard; Jean-Louis Pujol; Vicente Alberola; A Monnier; A Riviere; P Lianes; P Chomy; S Cigolari
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):360-7.
1994: Alain Rivière; A Le Cesne; J Berille; S Baio; Thierry Le Chevalier
Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial.
European journal of cancer (Oxford, England : 1990) 1994;30A(5):587-90.
1993: Rodrigo Arriagada; Thierry Le Chevalier; Jean-Pierre Pignon; Alain Rivière; I Monnet; P Chomy; C Tuchais; M Tarayre; Pierre Ruffié
Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer.
The New England journal of medicine 1993;329(25):1848-52.
1993: P Berthaud; I Eugène-Jolchine; Marc Spielmann; Thierry Le Chevalier; Thomas Tursz
[Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors].
Bulletin du cancer 1993;80(5):418-30.
1993: Jacques Rouëssé; Marc Spielmann; F Turpin; Thierry Le Chevalier; M Azab; J M Mondésir
Phase II study of elliptinium acetate salvage treatment of advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):856-9.
1992: L Kayitalire; F Thomas; Thierry Le Chevalier; C Toussaint; Thomas Tursz; Marc Spielmann
Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer.
Investigational new drugs 1992;10(4):303-7.
1992: Rodrigo Arriagada; Andrew Kramar; Thierry Le Chevalier; H De Cremoux
Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(3):447-51.
1992: Thierry Le Chevalier
[Do clinical and non-specific biological data influence staging?].
Revue des maladies respiratoires 1992;9 Suppl 4():R305-8.
1992: E Nasr; B Pellae-Cosset; Rodrigo Arriagada; Thierry Le Chevalier; P Baldeyrou; P Ruffie; H de Cremoux; M Martin; M Tarayre
[Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].
Bulletin du cancer 1992;79(7):681-7.
1992: P Berthaud; Thierry Le Chevalier; P Ruffie; P Baldeyrou; Rodrigo Arriagada; F Besson; Thomas Tursz
Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1863-5.
1992: Thierry Le Chevalier; Rodrigo Arriagada; M Tarayre; M J Lacombe-Terrier; Agnès Laplanche; Elisabeth Quoix; P Ruffie; M Martin; Jean-Yves Douillard
Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma.
Journal of the National Cancer Institute 1992;84(1):58.
1991: Axel Le Cesne; Thierry Le Chevalier; P Caille; E Cvitkovic; Genevieve Contesso; Marc Spielmann; J Rouesse
[Metastases from cancers of unknown primary site. Data from 302 autopsies].
Presse médicale (Paris, France : 1983) 1991;20(29):1369-73.
1991: Thierry Le Chevalier; F Thomas; R Subirana; P Baldeyrou; P Ruffie; Rodrigo Arriagada; M Chazard; Thomas Tursz
A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
Cancer 1991;67(12):2980-3.
1991: Rodrigo Arriagada; Thierry Le Chevalier; Elisabeth Quoix; P Ruffie; H de Cremoux; Jean-Yves Douillard; M Tarayre; Jean-Pierre Pignon; Agnès Laplanche
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
International journal of radiation oncology, biology, physics 1991;20(6):1183-90.
1991: Thierry Le Chevalier; Rodrigo Arriagada; Elisabeth Quoix; P Ruffie; M Martin; M Tarayre; M J Lacombe-Terrier; Jean-Yves Douillard; Agnès Laplanche
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
Journal of the National Cancer Institute 1991;83(6):417-23.
1991: Thomas Tursz; T Dorval; P Berthaud; M Jouve; Marie-Françoise Avril; E Garcia-Giralt; Thierry Le Chevalier; Marc Spielmann; D Sevin; T Palangie
[Phase I trial of a recombinant human interleukin 2. Results in patients with disseminated solid tumors].
Presse médicale (Paris, France : 1983) 1991;20(6):250-4.
1991: Rodrigo Arriagada; B Pellae-Cosset; J C Ladron de Guevara; H el Bakry; F Benna; M Martin; H de Cremoux; P Baldeyrou; M L Cerrina; Thierry Le Chevalier
Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20(2):91-8.
1990: Rodrigo Arriagada; H Mouriesse; Marc Spielmann; A Mezlini; P Oudinot; Thierry Le Chevalier; C Cuvier; F Fontaine; Jean-Paul Travagli; F May-Levin
Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer.
International journal of radiation oncology, biology, physics 1990;19(5):1207-10.
1990: Rodrigo Arriagada; Jean-Marc Cosset; Thierry Le Chevalier; M Tubiana
The value of adjunctive radiotherapy when chemotherapy is the major curative method.
International journal of radiation oncology, biology, physics 1990;19(5):1279-84.
1990: Rodrigo Arriagada; Thierry Le Chevalier; P Ruffie; P Baldeyrou; H De Cremoux; M Martin; P Chomy; M L Cerrina; B Pellae-Cosset; M Tarayre
Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group.
International journal of radiation oncology, biology, physics 1990;19(5):1135-8.
1990: B Pellae-Cosset; Rodrigo Arriagada; Thierry Le Chevalier
[Combined radiotherapy-chemotherapy in inoperable bronchial carcinoma (small cell carcinoma excluded)].
Bulletin du cancer 1990;77(8):759-67.
1989: Thierry Le Chevalier; C Zabbe; S Gouva; M L Cerrina; Elisabeth Quoix; A Riviere; P Berthaud; C Prache; J Berille
Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
European journal of cancer & clinical oncology 1989;25(11):1651-2.
1989: P Berthaud; Thierry Le Chevalier; J Berille; P Herait; P Baldeyrou; Thomas Tursz; Rodrigo Arriagada; Marc Spielmann; M Hayat
Phase II study of pirarubicin in advanced non-small cell lung cancer.
European journal of cancer & clinical oncology 1989;25(10):1507-8.
1989: P Berthaud; Thierry Le Chevalier; J Berille; P Herait; P Baldeyrou; Thomas Tursz; Rodrigo Arriagada; Marc Spielmann; M Hayat
Phase II study of pirarubicin in advanced non-small cell lung cancer.
European journal of cancer & clinical oncology 1989;25(9):1337-8.
1989: James R Treat; S C Falchuk; C Tremblay; M Spielman; P V Woolley; J Rouesse; D Sevin; Thierry Le Chevalier
Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary.
European journal of cancer & clinical oncology 1989;25(7):1053-5.
1989: D Sarrazin; Monique G Lê; Rodrigo Arriagada; Genevieve Contesso; F Fontaine; Marc Spielmann; F Rochard; Thierry Le Chevalier; J Lacour
Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;14(3):177-84.
1989: Jacques Rouëssé; D Sarrazin; Marc Spielmann; Thierry Le Chevalier; P Oudinot; I Guasch Jordan; H Mouriesse; F M Levin
[Treatment of inflammatory cancer of the breast. Combined chemotherapy and radiotherapy. Apropos of 270 women treated at the Institut Gustave-Roussy].
Bulletin du cancer 1989;76(1):87-92.
1989: Alain Rivière; D Abouz; P Ayela; P Berthaud; Marc Frenay; jean leon lagrange; Jean-Louis Pujol; J Robillard; Thierry Le Chevalier
[Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer].
Bulletin du cancer 1989;76(10):1095-102.
1989: B Pellae-Cosset; Rodrigo Arriagada; F Benna; Thierry Le Chevalier
[Role of radiotherapy in the treatment of small cell lung carcinoma].
Revue de pneumologie clinique 1989;45(5):194-8.
1989: Rodrigo Arriagada; H de The; Thierry Le Chevalier; F Thomas; P Ruffie; H de Cremoux; M Martin; P Duroux; J Dewar; Hélène Sancho-Garnier
Limited small cell lung cancer: possible prognostic impact of initial chemotherapy doses.
Bulletin du cancer 1989;76(6):604-15.
1988: F Thomas; Rodrigo Arriagada; H Mouriesse; I Sillet-Bach; Ian H Kunkler; F Fontaine; Thierry Le Chevalier; Genevieve Contesso; D Sarrazin
Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;13(4):267-76.
1988: Rodrigo Arriagada; Thierry Le Chevalier
[Therapeutic advances in small cell bronchial cancers].
Presse médicale (Paris, France : 1983) 1988;17(36):1851-6.
1988: Thierry Le Chevalier; E Cvitkovic; P Caille; J Harvey; Genevieve Contesso; Marc Spielmann; J Rouesse
Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients.
Archives of internal medicine 1988;148(9):2035-9.
1988: Z Pastran; Thierry Le Chevalier; P Baldeyrou; Marc Spielmann; Rodrigo Arriagada; Jean Pierre Droz; J Rouesse
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
European journal of cancer & clinical oncology 1988;24(6):1073-4.
1988: Thierry Le Chevalier
Review of toxicity and long-term sequelae in lung cancer.
Antibiotics and chemotherapy 1988;41():199-203.
1988: Rodrigo Arriagada; J R Bertino; N M Bleehen; O Brodin; R Feld; J H Goldie; H H Hansen; D C Ihde; Thierry Le Chevalier; R L Souhami
Consensus report on combined radiotherapy and chemotherapy modalities in lung cancer.
Antibiotics and chemotherapy 1988;41():232-41.
1988: Rodrigo Arriagada; H De Thé; F Thomas; H de Cremoux; J Dewar; Hélène Sancho-Garnier; Thierry Le Chevalier
Prognostic value of initial chemotherapy doses in limited small cell lung cancer.
Antibiotics and chemotherapy 1988;41():194-8.
1988: Thierry Le Chevalier; Rodrigo Arriagada; F Thomas; P Baldeyrou; P Ruffie; H de Cremoux; M Martin; M L Cerrina; H De Thé; M Tarayre
Experience of the Institut Gustave-Roussy in alternating radiotherapy and chemotherapy schedules as induction treatment in limited small-cell lung cancer.
Antibiotics and chemotherapy 1988;41():190-3.
1988: F Thomas; Thierry Le Chevalier; Rodrigo Arriagada; Pierre Ruffié; P Baldeyrou
Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma?
Antibiotics and chemotherapy 1988;41():138-41.
1988: F Thomas; Rodrigo Arriagada; Thierry Le Chevalier; M F Poupon
[Recent progress in the biology of small cell bronchial carcinoma].
Revue des maladies respiratoires 1988;5(5):451-61.
1988: Thierry Le Chevalier; Rodrigo Arriagada; H de Thé; H De Cremoux; M Martin; P Baldeyrou; Pierre Ruffié; F Benna; M L Cerrina; Hélène Sancho-Garnier
Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients.
NCI monographs : a publication of the National Cancer Institute 1988;(6):335-8.
1987: Jacques Rouëssé; Marc Spielmann; Thierry Le Chevalier; Rodrigo Arriagada; H Mouriesse; J N Munck; J L Amiel; C Toussaint; D Sarrazin; F May-Levin
[Initial chemotherapy in the treatment of inflammatory breast cancers. 230 cases].
Presse médicale (Paris, France : 1983) 1987;16(10):475-8.
1987: José-Luis Pico; D Baume; M Ostronoff; Françoise Beaujean; Alain Gouyette; Thierry Le Chevalier; Rodrigo Arriagada; P Rebattu; M Hayat
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].
Bulletin du cancer 1987;74(5):587-95.
1987: Thierry Le Chevalier; Rodrigo Arriagada; Pierre Ruffié
[Long-term survival of patients treated for small cell bronchial cancers].
Bulletin du cancer 1987;74(5):581-5.
1987: Rodrigo Arriagada; Thierry Le Chevalier; F Benna; M Martin
[Prophylactic brain irradiation in small cell bronchial carcinomas].
Bulletin du cancer 1987;74(5):569-73.
1987: Thierry Le Chevalier; Rodrigo Arriagada; P Baldeyrou; H de Cremoux; Pierre Ruffié; M Martin; M L Cerrina; G de Thé; Hélène Sancho-Garnier; M Hayat
[Chemo-radiotherapy combination in small cell bronchial carcinomas. Limitations and results in 109 patients treated with an alternating protocol].
Bulletin du cancer 1987;74(5):559-64.
1987: Pierre Ruffié; Thierry Le Chevalier
[Chemotherapy in small cell bronchial carcinoma].
Bulletin du cancer 1987;74(5):531-40.
1986: jean leon lagrange; Philippe Despins; M Spielman; Thierry Le Chevalier; AY De Lajartre; F Fontaine; D Sarrazin; Genevieve Contesso; J Génin; J Rouesse
Cardiac metastases. Case report on an isolated cardiac metastasis of a myxoid liposarcoma.
Cancer 1986;58(10):2333-7.
1985: Thierry Le Chevalier; F P Smith; P Caille; J P Constans; J G Rouesse
Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases.
Cancer 1985;56(4):880-2.
1985: J G Rouësse; Thierry Le Chevalier; P Caille; J M Mondesir; H Sancho-Garnier; F May-Levin; Marc Spielmann; R De Jager; J L Amiel
Phase II study of elliptinium in advanced breast cancer.
Cancer treatment reports 1985;69(6):707-8.
1985: Thierry Le Chevalier; Rodrigo Arriagada; P Baldeyrou; M Martin; P Duroux; A Jacquotte; H Sancho-Garnier; J Rouesse
Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
Cancer treatment reports 1985;69(5):469-72.
1985: Marc Spielmann; J Kac; D Elias; P Caille; Thierry Le Chevalier; P Rougier; K Zummer; Philippe Lasser; J Rouesse
[Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases].
Bulletin du cancer 1985;72(3):220-6.
1985: Thierry Le Chevalier; Rodrigo Arriagada; P Baldeyrou; M Martin; Pierre Ruffié; P Duroux; M Tarayre; J Rouesse
[Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy].
Bulletin du cancer 1985;72(1):25-9.
1985: Marc Spielmann; C Toussaint; G Malcoste; Thierry Le Chevalier; J M Mondésir; Genevieve Contesso; D Sarrazin; J Genin; J Rouesse
[Mesenchymal breast sarcomas. Apropos of 25 cases].
Bulletin du cancer 1985;72(3):202-9.
1984: J L Amiel; J Rouessé; J P Droz; P Caille; J P Travagli; Christine Théodore; Thierry Le Chevalier; J P Ducret; M Bidart; H S Garnier
[Treatment of metastatic renal cancer in adults with elliptinium acetate].
Presse médicale (Paris, France : 1983) 1984;13(25):1555-7.
1984: Rodrigo Arriagada; JJ Bretel; J M Caillaud; L Garreta; R A Guerin; A Laugier; Thierry Le Chevalier; Michel Schlienger
Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases.
European journal of cancer & clinical oncology 1984;20(1):69-74.
1983: Jacques Rouëssé; Thierry Le Chevalier; G Contesso; D Sarrazin; J L Amiel; D Sevin; P Carde; J Génin
[Primary chemotherapy in soft tissue sarcomas considered inoperable].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1983;59(19):1441-4.
1982: F Dreyfus; Thierry Le Chevalier; J P Constans; C Bognel; J Rouesse; C Haie
[Meningeal carcinomatosis in adults (author's transl)].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1982;58(12):719-23.
1982: Jacques Rouëssé; Thierry Le Chevalier; J P Constans; P Caille; J M Mondésir; A Boddaert
[Manifestations of cerebral metastases: diagnostic and therapeutic importance of research on their primary sites in 120 cases].
Bulletin du cancer 1982;69(2):159-63.
1981: J Rouesse; Thomas Tursz; Thierry Le Chevalier; D Huertas; J L Amiel; G Brule; B Callet; Jean Pierre Droz; P M Voisin; H Sancho-Garnier; J B Le Pecq; C Paoletti
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
La Nouvelle presse médicale 1981;10(24):1997-9.
1981: Jacques Rouëssé; D Huertas; H Sancho-Garnier; Thierry Le Chevalier; J L Amiel; G Brulé; Thomas Tursz; J M Mondésir
[2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)].
Bulletin du cancer 1981;68(5):437-41.